SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-022289
Filing Date
2014-03-20
Accepted
2014-03-20 18:39:12
Documents
1
Period of Report
2014-03-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 17920
  Complete submission text file 0001209191-14-022289.txt   19900
Mailing Address 275 SHORELINE DRIVE SUITE 450 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE SUITE 450 REDWOOD CITY CA 94065 6509638580
Versartis, Inc. (Issuer) CIK: 0001513818 (see all company filings)

IRS No.: 244106690 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences Fund I LP (Reporting) CIK: 0001601363 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 14707781

Mailing Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158 NORTH GOWER STREET LONDON X0 NW1 2ND 44 (0) 207 932 2120
Advent Life Sciences LLP (Reporting) CIK: 0001601364 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36361 | Film No.: 14707782